Printer Friendly
The Free Library
14,792,997 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ACADIA Pharmaceuticals to Present at the 25th Annual JP Morgan Healthcare Conference on January 11, 2007.


SAN DIEGO -- ACADIA Acadia (əkā`dēə), Fr. Acadie, region and former French colony, E Canada, encompassing modern Nova Scotia but also New Brunswick, Prince Edward Island, and coastal areas of E Maine. After an abortive 1604 settlement of St.  Pharmaceuticals Inc. (Nasdaq:ACAD ACAD Academy
ACAD Academic
ACAD AutoCAD (design/drafting development software by Autodesk)
ACAD Acadia National Park (US National Park Service)
ACAD Atherosclerotic Coronary Artery Disease
), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders Nervous system disorders

A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency
, today announced that it will present at the 25th Annual JP Morgan Healthcare Conference on Thursday, January 11, 2007, at 1:00 p.m. Pacific Time at The Westin St. Francis Hotel The Westin St. Francis is a luxury hotel in the Union Square district of San Francisco, California. The hotel opened on March 21, 1904. The interior was destroyed in the 1906 Earthquake but the structure survived and the hotel re-opened in late 1907.  in San Francisco.

A live webcast of ACADIA's presentation will be accessible on the company's website, www.acadia-pharm.com, under the investors section and an archived recording will be available on the website through January 25, 2007.

About ACADIA Pharmaceuticals

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has five clinical programs as well as a portfolio of preclinical and discovery assets directed at large unmet medical needs, including schizophrenia, Parkinson's disease psychosis, sleep maintenance insomnia, and neuropathic pain. All of the drug candidates in ACADIA's product pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA's corporate headquarters is located in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
 and it maintains research and development operations in both San Diego and Malmo, Sweden.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 3, 2007
Words:198
Previous Article:HP and TANDBERG to Deliver Full Portfolio of Visual Collaboration Solutions.
Next Article:InfoWorld Selects Zenprise as a Technology of the Year.
Topics:



Related Articles
Elan to Present at Healthcare Conferences in January 2006.
Panacos to Present at JP Morgan 24th Annual Healthcare Conference.
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.
Elan to Present at the 25th Annual JP Morgan Healthcare Conference.
Illumina to Present at the 25th Annual JP Morgan Healthcare Conference.
ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 13, 2007.
ACADIA Pharmaceuticals to Present at Lehman Brothers 10th Annual Global Healthcare Conference.
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.
ACADIA Pharmaceuticals to Announce First Quarter 2007 Financial Results on May 8, 2007.(Financial report)
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles